Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-046520
Filing Date
2026-02-11
Accepted
2026-02-11 16:05:26
Documents
60
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q vivs-20251231.htm   iXBRL 10-Q 2457614
2 EX-31.1 vivs-ex31_1.htm EX-31.1 14112
3 EX-31.2 vivs-ex31_2.htm EX-31.2 14080
4 EX-32.1 vivs-ex32_1.htm EX-32.1 11784
  Complete submission text file 0001193125-26-046520.txt   8470237

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT vivs-20251231.xsd EX-101.SCH 1172947
62 EXTRACTED XBRL INSTANCE DOCUMENT vivs-20251231_htm.xml XML 1316458
Mailing Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121
Business Address 11555 SORRENTO VALLEY ROAD SUITE 100 SAN DIEGO CA 92121 858-224-1000
VivoSim Labs, INC. (Filer) CIK: 0001497253 (see all company filings)

EIN.: 271488943 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-35996 | Film No.: 26620689
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)